Engaging Patients & Maximizing Visits through Telemedicine

Product not yet rated

Includes a Live Event on 03/17/2021 at 12:00 PM (EDT)

  • Register
    • Non-Member - $39
    • Regular Member - Free!
    • Retired - Free!
    • Early Career Physician - Free!
    • Resident - Free!
    • Student - Free!
    • Associate - Free!
    • ASAM Staff - Free!
    • International Member - Free!
    • Emeritus Member - Free!
    • Provisional Member - Free!
    • Fellow Member - Free!
    • Honorary Member - Free!
    • CRT Member - Free!

image

Engaging Patients & Maximizing Visits through Telemedicine


Treatment delivery via telemedicine has become an effective way for patients with substance use disorders to continue their treatment during the COVID-19 pandemic and is helping providers treat traditionally hard-to-reach populations. Research shows that telemedicine interventions are associated with high patient satisfaction and are an effective alternative to in-person treatment, especially when access to treatment is otherwise limited. Although telemedicine can be effective, it also poses unique challenges for providers such as regulatory compliance issues, patient engagement considerations, patient access barriers, and the need to transition systems to support virtual delivery of services. 

Join this session to hear from a Chief Executive Officer and Medical Director of an addiction treatment center that offers multi-disciplinary telemedicine services across the United States and learn how to overcome many of these common challenges. 

Session Information

Date:  Wednesday, March 17, 2021

Time: 12:00-1:00pm ET (11am CT, 10am MT, 9am PT) 

Speaker(s): 

  • David Kan, MD, DFASAM
  • Jonathan Ciampi

Learning Objectives

By completing this session, you will be able to:

  1. Identify telemedicine-based solutions to common challenges with patient engagement and retention.
  2. Create effective organizational systems to support patients in accessing treatment via telemedicine.
  3. Utilize strategies to better engage patients during telemedicine visits to maximize sessions.
  4. Describe the basic issues regarding regulatory compliance when adopting telemedicine.

David Kan, MD, DFASAM

Chief Medical Officer

Bright Heart Health

Dr. David Kan graduated from Northwestern University Medical School. He completed his general and forensic psychiatry training at the University of California, San Francisco. The majority of Dr. Kan's career has been spent in opioid treatment. Dr. Kan was the Medical Director of San Francisco VA Medical Center Opioid Treatment Program from 2005-2015 and he is the current Medical Director of Bright Heart Health. Dr. Kan is a faculty member within the UCSF Department of Psychiatry. Dr. Kan has won several awards for excellence in teaching. In addition to his psychiatry practice, Dr. Kan consults to attorneys and courts on medical-legal matters. Dr. Kan serves on California state's State Opioid Safety Workgroup. Dr. Kan is active within ASAM. Dr. Kan is the current President of the California Society of Addiction Medicine.

Jonathan Ciampi

Chief Executive Officer

Bright Heart Health

Jonathan Ciampi is the Chief Executive Officer of Bright Heart Health which provides telemedicine services for substance use, mental health, eating disorders, and chronic pain across the United States. Previously, Mr. Ciampi was Chief Marketing Officer at CRC Health Group, where he oversaw more than 160 substance abuse and eating disorder programs across the United States. Prior to CRC Health, he was involved in several technology companies from 1997 to 2011. Most notably, he was Vice President and General Manager of SumTotal Systems, a publicly traded company providing human resources software. He have led teams across marketing, sales, business development, corporate development, product management, services, support, r&d, operations, hosting, and finance.

Credits and Disclosures


ACCME Accredited with Commendation

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Board for Certified Counselors ACEP

The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

NAADAC, the Association for Addiction Professionals

This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification


American Board of Preventive Medicine (ABPM)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credits towards ABPM MOC Part II requirements.

American Board of Anesthesiology (ABA)

This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

American Board of Surgery (ABS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

American Board of Psychiatry and Neurology (ABPN)

Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

American Board of Addiction Medicine (ABAM)

Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

CME Reviewer and Disclosure Information


ASAM CME Committee Reviewer

Herbert Malinoff, MD, FACP, DFASAM – No Relevant Financial Disclosures 

Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Faculty and Planning Committee


Faculty Disclosure Information

David Kan, MD DFASAM – Does Disclose

  • Bright Heart Health (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Jonathan Ciampi – Does Disclose

  • Bright Heart Health, Inc., Individuals Involved: Self, Clinical Condition, Type of financial relationship. (Select all that apply.): Employment, Ownership Interest (includes stock, stock options, patent or other intellectual property), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received)
  • Lyssn, Inc., Individuals Involved: Self, Clinical Condition: Type of financial relationship. (Select all that apply.): Consultant/Advisory Board, Ownership Interest (includes stock, stock options, patent or other intellectual property)

Planning Committee Disclosure Information

Miriam S. Komaromy, MD, FACP, DFASAM – No Relevant Financial Disclosures

Key:

Complete
Failed
Available
Locked
Engaging Patients & Maximizing Visits through Telemedicine
03/17/2021 at 12:00 PM (EDT)   |  60 minutes
03/17/2021 at 12:00 PM (EDT)   |  60 minutes This session discusses how to utilize telemedicine to treat patients with substance use disorders including regulatory compliance issues, patient engagement considerations, patient access barriers, and the need to transition systems to support virtual delivery of services.
CME Evaluation
17 Questions
17 Questions Please complete the evaluation to claim CME.
Credit and Certificate
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available This webinar has been approved for 1 AMA PRA Category 1 Credit.